Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 10, 2026, 3:41 PM EST
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $2.68 thousand as of July 10, 2026. Its market cap has decreased by -99.63% in one year.
Market Cap
2.68K
Enterprise Value
n/a
Revenue
386.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 2.68K, a decrease of -100.00%. That is a compound annual growth rate of -69.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.68K | -71.43% |
| Dec 31, 2025 | 9.39K | -99.85% |
| Dec 31, 2024 | 6.17M | -96.96% |
| Dec 29, 2023 | 202.59M | 179.01% |
| Dec 30, 2022 | 72.61M | -64.04% |
| Dec 31, 2021 | 201.95M | -59.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synovics Pharmaceuticals | 3.65K |
| Aditxt | 3.59K |
| Rebus Holdings | 3.21K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| eFFECTOR Therapeutics | 2.82K |
| Anthera Pharmaceuticals | 2.62K |
| OncoVista Innovative Therapies | 2.36K |